Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Titel:
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Auteur:
Laubach, Jacob P Schjesvold, Fredrik Mariz, Mário Dimopoulos, Meletios A Lech-Maranda, Ewa Spicka, Ivan Hungria, Vania T M Shelekhova, Tatiana Abdo, Andre Jacobasch, Lutz Polprasert, Chantana Hájek, Roman Illés, Árpád Wróbel, Tomasz Sureda, Anna Beksac, Meral Gonçalves, Iara Z Bladé, Joan Rajkumar, S Vincent Chari, Ajai Lonial, Sagar Spencer, Andrew Maison-Blanche, Pierre Moreau, Philippe San-Miguel, Jesus F Richardson, Paul G